{"filing":{"accession_number":"0001213900-26-094654","cik":"0001840425","ticker":"OSRHW","company_name":"OSR Health, Inc.","form":"8-K","filing_date":"2026-08-28","report_date":"2026-08-27","primary_document":"ea0303794-8k_osrhealth.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1840425/000121390026094654/ea0303794-8k_osrhealth.htm"},"events":[{"id":30193,"run_id":27676,"accession_number":"0001213900-26-094654","anchor_item_number":"8.01","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"summary":"The filing discloses that Nasdaq's Staff determined the Company should be delisted, trading was suspended on August 26, 2026, and the Company has scheduled a hearing before the Nasdaq Hearings Panel on September 29, 2026 to appeal the delisting determination and request continued listing. The Company explicitly acknowledges \"there can be no assurance that the Panel will grant the Company's request for continued listing,\" indicating material delisting risk under Item 8.01.","company_name":"OSR Health, Inc.","ticker":"OSRHW","filing_date":"2026-08-28","form":"8-K","submitted_at":null,"items":[{"id":32724,"accession_number":"0001213900-26-094654","item_number":"8.01","item_title":"Other Events.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"The filing discloses that Nasdaq's Staff determined the Company should be delisted, trading was suspended on August 26, 2026, and the Company has scheduled a hearing before the Nasdaq Hearings Panel on September 29, 2026 to appeal the delisting determination and request continued listing. The Company explicitly acknowledges \"there can be no assurance that the Panel will grant the Company's request for continued listing,\" indicating material delisting risk under Item 8.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-28T12:02:07.615469+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":32724,"accession_number":"0001213900-26-094654","item_number":"8.01","item_title":"Other Events.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"The filing discloses that Nasdaq's Staff determined the Company should be delisted, trading was suspended on August 26, 2026, and the Company has scheduled a hearing before the Nasdaq Hearings Panel on September 29, 2026 to appeal the delisting determination and request continued listing. The Company explicitly acknowledges \"there can be no assurance that the Panel will grant the Company's request for continued listing,\" indicating material delisting risk under Item 8.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-28T12:02:07.615469+00:00","company_name":"OSR Health, Inc.","ticker":"OSRHW","filing_date":"2026-08-28"}]}